Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 25 Sept 2026 for Definium Therapeutics, Inc., €453k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Mark Sullivan: trading record in brief
All filings by Mark Sullivan on record concern Definium Therapeutics, Inc. We count 2 filings; the first trade dates from 25 June 2026 and the latest from 25 September 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 25 September 2026: a transaction of €453k, in Definium Therapeutics, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Mark Sullivan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
14,051 shares@ US$36.73CommonSEC144:0001950047-26-009823
13,008 shares@ US$42.13100.0% of flowCommonSEC144:0001950047-26-006493
2 of 2 declarations
